findinEsegui ricerca

TTS Europe 2013

1–2 July 2013 - Wellcome Collection, London

TTS Europe 2013

ENTENTE is pleased to announce the TTS Europe; Europe's only interactive round-table summit of high-level, early-stage biotech innovation KOLs and decision-makers from across all of the key stakeholder groups; tech transfer, public research, patient organizations, foundations, venture capital, corporate venture, investment banks, start-ups, SMEs, big pharma, and industry.

Don’t miss it.  The only place where biotech TTOs can have direct, open discussion and debate with senior pharma and biotech executives and the leading European VCs, as well as many of the most eminent TTOs in the business, all there to speak openly under the Chatham House rule and share their expertise and experience and provide sincere feedback.

The result is an atmosphere of discussion, debate and collaboration unlike anything else in our sector, providing you better access to top pharma and biotech executives and investors than most tech transfer offices are likely to have during the course of the year.
 Please do not miss out.

The TTS Europe is the flagship European summit of the TTS Global Initiative, and is an entirely unique meeting in the biotech sector. Limited to 170 key early-stage biotech and tech transfer innovators and decision makers, the TTS brings together a high-level cross section from all the leading stakeholder groups; its interactive format encourages open, serious moderated debate under the Chatham House rule, which provides an atmosphere of discussion, debate and collaboration unlike anything else in our sector.

Special presentation on the ENTENTE project and the ENTENTE TTO Professional Exchanges of secondments for TTOs, into top TT offices and into actual pharma BD&L teams and VC funds.  What it is, how it works, announcing the second call for applications, and the evaluation criteria and submitting a high-quality application.

Early registration until 14 June.

ENTENTE invitees receive special, further reduced rates providing access at the lowest possible rates for key biotech innovation, tech transfer and early-stage stakeholders.  Register before 14 June for the early registration rates, and using the Code ENTE13 for an additional discount, provides rates of just £399 (regularly £599) for academia, non-profit and charities, and £699 for Industry (regularly £999.


Share with
. . .
Inside News & Events
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA